Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|January 24, 2007
[Critical review of mechanisms of action of second-generation antipsychotic drugs]Seiya MiyamotoNihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|June 24, 2016
[Effectiveness of N-acetylcysteine in the treatment of schizophrenia]Nobumi Miyake, Seiya MiyamotoNihon Rinsho. Japanese Journal of Clinical Medicine|May 18, 2013
[Blonanserin in the treatment of schizophrenia]Tomomi Tenjin, Seiya MiyamotoCurrent Treatment Options in Psychiatry|June 6, 2017
The Use of Long-Acting Injectable Antipsychotics in SchizophreniaSeiya Miyamoto, W Wolfgang FleischhackerClinical Schizophrenia & Related Psychoses|September 26, 2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?Nobumi Miyake, Seiya Miyamoto, L Fredrik JarskogJournal of Psychiatric Research|July 30, 2014
New therapeutic approaches for treatment-resistant schizophrenia: a look to the futureSeiya Miyamoto, L Fredrik Jarskog, W Wolfgang FleischhackerCurrent Opinion in Psychiatry|March 14, 2015
Schizophrenia: when clozapine failsSeiya Miyamoto, Lars Fredrik Jarskog, W Wolfgang FleischhackerAnnual Review of Medicine|August 15, 2006
Schizophrenia: new pathological insights and therapiesL Fredrik Jarskog, Seiya Miyamoto, Jeffrey A LiebermanCurrent Opinion in Psychiatry|January 5, 2013
Alternative pharmacologic targets for the treatment of schizophrenia: results from phase I and II trialsSeiya Miyamoto, Lars F Jarskog, W Wolfgang FleischhackerThe Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activationGary E Duncan, Seiya Miyamoto, Jeffrey A LiebermanPageof 3